Internal Medicine Doctors in Represa, CA Accepting Medicare
2 Internal Medicine doctors found. Showing 1 - 2
 Benjamin Lee, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 Prison Rd, Represa, CA 95671 Phone: 916-985-2561 |
Dr. Bennett Feinberg, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 Prison Rd, Medical Offices - Folsom State Prison, Represa, CA 95671 Phone: 916-985-2561 |
News Archive
Drug companies paid to attend FDA advisory panel meeting on painkillers' safety and effectiveness
A scientific panel that shaped the federal government's policy for testing the safety and effectiveness of painkillers was funded by major pharmaceutical companies that paid hundreds of thousands of dollars for the chance to affect the thinking of the Food and Drug Administration, according to hundreds of e-mails obtained by a public records request.
Call for papers, panels and posters for 2010 Pacific Rim Summit now open
The Biotechnology Industry Organization invites leaders from the biotechnology, chemical and agricultural industries to submit proposals and abstracts for panels, individual papers, and posters for the 2010 Pacific Rim Summit on Industrial Biotechnology and Bioenergy. This unique conference will be held Dec. 11-14, 2010 in Honolulu.
Senate Finance Committee passes health bill, but with plenty of grumbling
The Senate Finance Committee yesterday became the fifth and final committee in Congress to pass a health care overhaul bill. The committee voted 14-9 in favor of the bill with Sen. Olympia Snowe, of Maine, joining all of the panel's Democrats to cast the sole Republican "yea" vote.
Cerenis Therapeutics closes first round of series C, raises €40 million
Cerenis Therapeutics SA (Cerenis), a biopharmaceutical company specializing in the research and development of novel therapies based on the metabolism of HDL (the "good" cholesterol) to treat cardiovascular and other metabolic diseases, announced today it has raised €40 million in the first close of its series C financing. In this round €20 million came from the Fund for Strategic Investment (FSI) with an additional €20 million coming from the existing investors: Sofinnova Partners, HealthCap, Alta Partners and TVM Capital, EDF Ventures, OrbiMed and DAIWA Corporate Investment.
Healthy San Francisco program prompts some companies to shift costs to consumers but appears effective
The Healthy San Francisco program has prompted some employers to increase prices and hire fewer new employees but also is "showing early signs of doing what it was intended to do: push employers to defray medical costs for more workers," the Wall Street Journal reports (Dvorak, Wall Street Journal, 5/5).
› Verified 6 days ago